FFA
SLS icon

Farther Finance Advisors’s SELLAS Life Sciences SLS Stock Holding History

Farther Finance Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.8K Hold
2,360
– – ﹤0.01% 3541
2026
Q1 		$9.94K Buy
2,360
+2,010
+574% +$8.99K ﹤0.01% 4121
2025
Q4 		$1.32K Buy
+350
New +$680 ﹤0.01% 4840

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
VH
Visionary Horizons Knoxville, Tennessee $239M AUM 22.35% 1-Year Est. Return
FD
Financial Designs Claremont, California $187M AUM 14.59% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.4B AUM 23.96% 1-Year Est. Return

Farther Finance Advisors's SLS Position: Q2 2026 in Review

Farther Finance Advisors held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 2,360 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3541.

Farther Finance Advisors first reported a position in SLS in Q4 2025 and has held it in 3 quarters since. 16 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Farther Finance Advisors held 2,360 shares of SELLAS Life Sciences worth $34.8K as of Q2 2026.
  • Farther Finance Advisors left its SELLAS Life Sciences share count unchanged in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3541 holding.
  • Farther Finance Advisors first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 16 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.